Semax + Selank research: quick summary
Semax + Selank 40 mg is a two-component blend supplied by Red Leaf Research Labs as a lyophilized research material, holding the heptapeptides Semax and Selank in one vial. Both came from Russian research programmes and share a C-terminal Pro-Gly-Pro extension, but are separate compounds with separate identifiers. It is not an authorized medicine in Canada, is for laboratory research only, is not for human or veterinary use, and carries no dosing information.
Semax + Selank Canada: Semax + Selank 40mg Research Product
Semax and Selank are held together in a single 40 mg lyophilized vial, sold to qualified laboratory purchasers in Canada. Material, lot paperwork and dispatch terms follow.
Researchers reaching this page commonly search buy Semax Selank Canada, Semax peptide Canada and Selank Canada. Those queries are logged as behaviour, not as uses the vial serves. A personal-health motive belongs with a clinician.
Red Leaf Research Labs supplies this blend as a research chemical. It is not sold for giving to people or animals, carries no dosing instruction, and nothing is claimed for either peptide.
Semax + Selank 40mg Research Format and Options
| Attribute | Detail |
|---|
| Research format | Single vial, 40 mg across Semax and Selank, freeze-dried |
| Physical state | One dried cake holding both peptides, glass vial under closure |
| Analytical documentation | Independent report on the current lot code, resolving both peptides |
| Fulfilment | Domestic dispatch, research addresses only |
| Intended use | Laboratory research only; not for human or veterinary use |
The 40 mg is the total across both. How it is apportioned is a property of the lot, read from its documentation.
Semax + Selank Research Specifications
A blend has no single CAS, formula or weight; each constituent is specified below.
- Compound name: Semax
- Alternative name(s): MEHFPGP, ACTH(4-7)-PGP
- Peptide/compound class: Synthetic heptapeptide, ACTH(4-10) analogue
- Receptor or pathway interest: Melanocortin receptors; enkephalin-degrading enzymes in vitro
- Structural origin: ACTH(4-7) plus a C-terminal Pro-Gly-Pro
- CAS: 80714-61-0
- Molecular formula: C37H51N9O10S
- Molecular weight: approximately 813.9 g/mol
- Compound name: Selank
- Alternative name(s): TKPRPGP, tuftsin-PGP
- Peptide/compound class: Synthetic heptapeptide, tuftsin analogue
- Receptor or pathway interest: Tuftsin-associated signalling; the same enzymes in vitro
- Structural origin: Tuftsin plus the same C-terminal extension
- CAS: 129954-34-3
- Molecular formula: C33H57N11O9
- Molecular weight: approximately 751.9 g/mol
- Research shorthand: Semax + Selank
- Physical format: Freeze-dried solid, one vial
- Available research quantity: 40 mg per vial
- Intended use: Laboratory research use only
- Fulfilment: Dispatched domestically inside Canada
What Is Semax + Selank?
Two peptides in one vial, not a single molecule or a conjugate. Semax is Met-Glu-His-Phe-Pro-Gly-Pro, ACTH(4-7) extended at the C-terminus. Selank is Thr-Lys-Pro-Arg-Pro-Gly-Pro, tuftsin with the same addition. Both are heptapeptides of similar mass, so a report must distinguish them.
The blend is most often confused with a single-compound vial: suppliers list Semax alone, Selank alone, or the pair under a compressed name, and a certificate for one does not describe this vial. A second confusion is with N-acetyl Semax.
Semax + Selank and Pro-Gly-Pro Peptide Research
The literature on both compounds is substantially Russian in origin, concentrated around the Institute of Molecular Genetics of the Russian Academy of Sciences. Independent replication outside that network is thinner than the marketing suggests. Reported work includes rodent behavioural and neurochemical experiments, brain-tissue gene expression, and enzymology on enkephalin degradation.
None of that is a claim about what either peptide does. An observation in a rodent, tissue preparation or enzyme assay does not establish an effect in a person, and the blend itself is uncharacterised there.
Why Buy Semax + Selank 40mg in Canada from a Domestic Research Supplier?
Transit is the ordinary argument: fewer carrier handoffs, fewer temperature transitions, no customs hold with no record.
The argument peculiar to this item is that the two peptides are dried into one cake and cannot be separated afterwards. How the 40 mg divides is a question only the supplier answers, and better asked in one jurisdiction.
Both concern supply, not composition. A short route says nothing about how much of the vial is Semax.
How This Semax + Selank Canada Page Improves on Typical Competitor Listings
Blend listings often give one specification for two compounds. This page differs five ways.
- Both constituents are specified separately: sequence, CAS, formula, weight.
- The analytical basis is stated, not asserted: a lot-tied report covering both peptides.
- Neither peptide is credited here with an effect, a benefit or a safety property.
- The regulatory position is explicit: Semax is registered in Russia; this vial is a different category.
- The origin of the evidence base is stated, and how concentrated it is.
How to Evaluate a Semax + Selank Certificate of Analysis
One cake, two analytes, and not chemically alike. Selank carries a lysine and an arginine and is strongly basic and polar; Semax is the more hydrophobic. A single gradient must retain and resolve both.
- Compound identity: both peptides named, CAS 80714-61-0 and 129954-34-3, matching the label.
- Lot reference: one lot code covering the vial, the blend being a single batch.
- Analysis date: the day the blend was tested, not when either peptide was made.
- Test methods: the separation described, and whether it holds a basic polar peptide as well as a hydrophobic one.
- Measured quantity: how the 40 mg divides, as a measured split rather than a nominal ratio.
- Purity result: a figure for each peptide, with the method behind it.
- Laboratory verification: the analysing laboratory named, and its distance from the seller.
Intact masses of 813.9 and 751.9 separate the two easily. Fragment data is weaker, both sequences ending in the same Pro-Gly-Pro. Sixteen daltons above Semax fits oxidation at its methionine.
Semax + Selank 40mg Lyophilized Research Format
The vial was filled as one solution of both peptides, frozen, then dried under vacuum until the ice had sublimed, which is what slows hydrolysis of either backbone.
Two properties of the pair matter afterwards. The methionine heading the Semax sequence is what stability work attends to, oxidation adding sixteen daltons; the basic residues of Selank make its salt the more hygroscopic. Co-dried, the components form one cake and cannot be recovered separately, so a handling decision applies to both. Records belong to the receiving institution.
How to Buy Semax + Selank in Canada for Qualified Research
- Confirm eligibility. Be satisfied your organization is cleared to hold research chemicals for this work.
- Review documentation. Read the lot report and check the split is measured, not nominal.
- Select quantity. Work out how many vials the plan needs from the split, not the total.
- Check shipping route. Line the route and window up against the hours goods are signed for.
- Record receipt. Book in the lot code, the date and the state of the cake.
Each step is procurement or records. None supplies dosing, ratio or design guidance.
Semax + Selank Availability in Canada: Research vs. Consumer Searches
Semax is a registered prescription medicine in Russia and appears on that country’s list of vital and essential drugs. It is not approved in Canada, and that gap is the point: a registered pharmaceutical is a specified formulation with approved labelling and prescriber oversight; a research vial is not.
Neither constituent has been assessed by Health Canada, and the blend has no status anywhere. Search traffic here is heavily consumer-driven; that interest belongs with a licensed clinician.
Semax + Selank 40mg Canada Procurement Checklist
| Check | What to confirm |
|---|
| Purpose | Laboratory research in an organization permitted to receive it |
| Identity | Both sequences named, CAS 80714-61-0 and CAS 129954-34-3 |
| Distinctness | A co-dried pair, not Semax or Selank alone, nor N-acetyl Semax |
| Quantity | The measured split of the 40 mg, and how many vials it implies |
| Documentation | One lot report resolving and reporting both peptides |
| Verification | Whether an outside laboratory will confirm the split |
| Handling | Storage set in advance for one cake holding both peptides |
Explore Semax + Selank Research Information
Background reading: Semax and its Soviet-era history, peptide terminology, third-party testing.
Semax + Selank research FAQ
Does Red Leaf Research Labs provide dosing information?
No. No dosing, reconstitution volume, concentration, route or protocol is given for this or any product.
How is the 40 mg split between the two peptides?
That is a property of the lot. Take it from the lot documentation, not a product description.
Are Semax and Selank the same kind of peptide?
They share a design pattern, a natural fragment extended with Pro-Gly-Pro, but differ in it: ACTH(4-7) against tuftsin.
Is Semax approved anywhere?
It is a registered prescription medicine in Russia, not authorized in Canada, and this vial is no version of it.
Can Red Leaf Research Labs advise on experimental design?
No. Choice of model, controls and endpoints rests with the purchasing laboratory alone.
Research use only. Semax + Selank 40 mg is supplied strictly for laboratory research. It is not an authorized medicine in Canada, is not for human or veterinary use, and carries no dosing or protocol information. A personal-health question about either peptide belongs with a licensed clinician.
Independent third-party testing
Janoshik Lab Reports
Review available analytical reports associated with this product.
ANALYTICAL
REPORT
Independent analysis
Selank
- Purity
- 99.809%
- Tested quantity
- 9.82 mg
- Report date
- March 25, 2026
- Task ID
- #123265
ANALYTICAL
REPORT
Independent analysis
Semax
- Purity
- 99.687%
- Tested quantity
- 9.98 mg
- Report date
- March 25, 2026
- Task ID
- #123264
A certificate describes the submitted sample shown in that report. It does not establish clinical safety, efficacy, or suitability for human or veterinary use.
Owned and operated by a cf veteran 
